Chapter 1. ANTIPARKINSONIAN DRUGS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. ANTIPARKINSONIAN DRUGS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. ANTIPARKINSONIAN DRUGS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. ANTIPARKINSONIAN DRUGS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. ANTIPARKINSONIAN DRUGS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. ANTIPARKINSONIAN DRUGS MARKET– By Drug Class

6.1. Anticholinergics

6.2. Catechol-O-Methyltransferase (COMT)-Inhibitors

6.3. Monoamine Oxidase Type B (MAO-B) Inhibitors

6.4. Dopamine Receptor Agonists

6.5. Levodopa/Carbidopa

6.6. Others

Chapter 7. ANTIPARKINSONIAN DRUGS MARKET– By Route of Administration

7.1. Oral

7.2. Injection

7.3. Transdermal

Chapter 8. ANTIPARKINSONIAN DRUGS MARKET– By Distribution Channel

8.1. Retailer Pharmacies

8.2. Online Pharmacies

8.3. Hospital Pharmacies

Chapter 9. ANTIPARKINSONIAN DRUGS MARKET– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. ANTIPARKINSONIAN DRUGS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10

Download Sample